Morning Market Losers By: Benzinga via Benzinga June 02, 2014 at 09:46 AM EDT Puma Biotechnology (NYSE: PBYI) shares declined 18.47% to $62.31 after the company presented positive PB272 Phase II data at ... Read More >> Related Stocks: Clovis Oncology Inc Mastec Inc Universal Elect IN